IL23A and Alzheimer disease: Despite new target-oriented anti-inflammatory IL4RA, IL13, IL31RA and IL23 antibodies [39] for severe cases, a holistic concept for the topical treatment of AD and regeneration of the skin’s barrier function at the cellular level is still lacking.